BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 529349)

  • 1. Chronic hepatitis B antigenaemia in patients with hepatosplenic schistosomiasis.
    Bassily S; Farid Z; Higashi GI; Kamel IA; El-Masry NA; Watten RH
    J Trop Med Hyg; 1979; 82(11-12):248-51. PubMed ID: 529349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis.
    Lyra LG; Rebouças G; Andrade ZA
    Gastroenterology; 1976 Oct; 71(4):641-5. PubMed ID: 955351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B surface antigen in serum, ascitic fluid and saliva in advanced hepatosplenic schistosomiasis.
    Farrag SA; Makarem SS; Montaser MF; el-Okbi LM; Khalil I
    J Egypt Soc Parasitol; 1988 Jun; 18(1):247-52. PubMed ID: 3373053
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic hepatitis B in patients with schistosomiasis mansoni.
    Bassily S; Dunn MA; Farid Z; Kilpatrick ME; El-Masry NA; Kamel IA; El Alamy M; Murphy BL
    J Trop Med Hyg; 1983 Apr; 86(2):67-71. PubMed ID: 6887317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [E antigen (HBeAG) and surface antigen (HBsAg) in bladder schistosomiasis].
    Nuti M; Abdullhai SE; Thamer G
    Parassitologia; 1978 Dec; 20(1-3):153-9. PubMed ID: 553266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects of hepatosplenic schistosomiasis: a contrast with cirrhosis.
    Rebouças G
    Yale J Biol Med; 1975 Nov; 48(5):369-76. PubMed ID: 128911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease.
    Colley DG; Garcia AA; Lambertucci JR; Parra JC; Katz N; Rocha RS; Gazzinelli G
    Am J Trop Med Hyg; 1986 Jul; 35(4):793-802. PubMed ID: 3089040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B and primary cancer of the liver in intertropical Africa].
    Coursaget P; Yvonnet B; Barres JL; Perrin J; Tortey E; Diop B; Kocheleff P; Duflo B; M'Boup S; Diop-Mar I
    Rev Epidemiol Sante Publique; 1985; 33(4-5):267-75. PubMed ID: 2419946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased hepatitis B infection in hepatosplenic schistosomiasis in the Sudan.
    Daneshmend TK; Homeida M; Satir AA; Vandervelde EM
    East Afr Med J; 1984 Feb; 61(2):133-5. PubMed ID: 6468320
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
    Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
    Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis.
    Chung HT; Lai CL; Lok AS
    Hepatology; 1995 Jul; 22(1):25-9. PubMed ID: 7601418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatitis B antigens systems in schistosomiasis mansoni].
    Guimarães RX; da Silva EC; Nigro SP; Kimura RT; Takeda A; de Almeida FM
    Arq Gastroenterol; 1981; 18(4):145-51. PubMed ID: 7347595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
    Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
    Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBV exposure and HBsAg positivity rates in schistosomiasis japonica: study in a Philippine community endemic for both infections.
    Domingo EO; Lingao AL; Tiu E; Lao JY; Olveda RM
    Southeast Asian J Trop Med Public Health; 1983 Dec; 14(4):456-62. PubMed ID: 6673120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of concurrent hepatitis B surface antigen and antibody to hepatitis B surface antigen with hepatocellular carcinoma in chronic hepatitis B virus infection.
    Jang JS; Kim HS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Kim DJ; Lee MS; Park CK; Jeong BH; Kim YS; Jang MK
    J Med Virol; 2009 Sep; 81(9):1531-8. PubMed ID: 19623669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Active chronic hepatitis and decompensated schistosomiasis].
    Andrade ZA; Sadigursky M; Gomes LS
    AMB Rev Assoc Med Bras; 1978 Nov; 24(11):366-8. PubMed ID: 85318
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of HBs-Ag in schistosomiasis: B-frequency in various stages of schistosomiasis.
    Zakaria S; el-Raziky EH; el-Kalouby AH; Shaker ZA; Hunter S; Ata AA; el-Battawy Y
    Egypt J Bilharz; 1979; 6(1-2):11-19. PubMed ID: 263093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.